iPLATO Smartphone mHealth Service Growing Rapidly

iPLATO HealthcareiPLATO Healthcare announced its GP service for Smartphones - iPLATO mSite - is now available to all its NHS partners across the United Kingdom. Due to the widespread availably of Smartphones many of iPLATO's NHS partners have embraced this new channel for patient engagement.

iPLATO mSite is a free of charge module for iPLATO Patient Care Messaging Pro users that allows surgeries to quickly create and manage content on their own mobile internet site. Smartphones such as iPhone, Blackberry and others currently account for more than 30% of all mobile phones in use in the UK. This percentage is rising rapidly.

Optimised for Smartphone access, iPLATO mSite has been designed to improve patient access to healthcare services and provides information that enables self-service.

"When designing iPLATO mSite" Tobias Alpsten, Managing Director of iPLATO Healthcare said "we tried to answer frequent questions that patients have when they call the surgery switchboard. This includes names of practitioners, opening hours, contact details, maps and how to get to the surgery by foot, car or public transport and information on how to access out of hours services.

"We believe that patients in 2011 expect more than text messages from their surgery. Our developers have worked on this feature for almost three years. It has been trialled with 30 surgeries over the last year to ensure that it is stable, safe and easy to use. After these extensive preparations I hope that our primary care partners will use iPLATO mSite to expand their mHealth services to patients."

If you are a GP surgery or other healthcare organisation who wants to expand your electronic services to reach patient's Smartphones please email This email address is being protected from spambots. You need JavaScript enabled to view it.

Related news articles:

About iPLATO
iPLATO Healthcare is an innovation company dedicated to mobile health since 2006. iPLATO's evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.

Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and pandemic awareness as well as mobile patient support services for people with diabetes, hypertension, epilepsy, COPD and HIV.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...